Monday, 23 November 2015 20:19

VQCC Differentials to Impact Providers: A Brief History of Changes in Long-Term, Post-Acute Care – Part 2

Written by


This is the second in a series of articles concerning long-term post-acute care (LTPAC) providers and vendors. In this article I will introduce the five major Valued Quality Care Coordination (VQCC) differentials and their value proposition as compared to other healthcare providers. In later articles I will go through each VQCC differential.

In May 2015, Dr. Karen DeSalvo, MD, of the Office of the National Coordinator (ONC) asked me to provide her with a brief on LTPAC. At first I jumped to the conclusion that I would write a paper about all the regulations that seem to have been piled on this sector of healthcare, the cuts in reimbursement, and finally the fact that we were left out of the 2009 ARRA HITECH Act incentive program to digitize and upgrade health information technology. After mulling a negative approach, I decided that other advocates of LTPAC have made a case for the regulatory pressures placed on this sector of care and that I would look at the glass as being half full, documenting the positive differentials of LTPAC care and the value we bring in coordinating care for individuals who are among the most vulnerable, clinically complex, and in many cases, the most costly. This value of LTPAC complements the role of acute and ambulatory care providers, making the sector a valuable partner to support patient-centered, longitudinal care. I also thought that the ONC brief should be quantifiable – not just a narrative, but containing facts about the value proposition of LTPAC.

In 2004, at the press conference for President Bush’s executive order digitizing healthcare and forming the Office of the National Coordinator, then-Secretary Thompson asked me to coordinate LTPAC. At the time I was executive vice president of the American Health Care Association/National Center for Assisted Living (AHCA/NCAL). I felt it was important to form an informal organization of the LTPAC provider and vendor stakeholders. At the time there was no single organization to represent the many providers and vendors that I outlined in an October VBPmonitor article. One of the problems that we faced in AHCA/NCAL was that our sector of care spoke to the regulatory agencies in multiple tongues and did not provide a single perspective on issues. I felt that when it came to clinical technology, we had to work together.

In 2005, AHCA/NCAL, LeadingAge, and the American Health Information Management Association (AHIMA) formed an informal group called the LTPAC Health IT Collaborative. The Collaborative is made up of the stakeholders in LTPAC that are represented by this slide of their logos:

Since 2005 we have had a conference call once a week on average, held a LTPAC Health IT Summit every June, and written four LTPAC Health IT road maps. The Collaborative has provided comments in response to every major health IT request for comments. This activity has been very important, as since we were not included in the HITECH Act, we could not have provided comments on the evolving field of clinical technology. Even though we were not to be included officially in the ONC programs, we were listened to by the directors and staff of ONC and given grants and other programs to ensure that we were included in spirit – especially in the area of interoperability and continuity of care across the spectrum of services in this era of person-centric electronic longitudinal care.

Prev Next »

Last modified on Monday, 23 November 2015 20:29

John F. Derr, RPh is CEO of JD & Associates Enterprises specializing in Strategic Clinical Technology with a focus on person centric electronic longitudinal medication management and LTPAC. He has over fifty years of top executive level experience Squibb, Siemens, Tenet (NME), Kyocera, MediSpan and EVP of AHCA. He was SVP, CIO and CTO for Golden Living, LLC. He is a member of Corporate Boards providing guidance on clinical Health IT and medication management. He represents LTPAC and Pharmacy as a member of HHS HITECH Committee on Standards. Derr is a graduate of Purdue School of Pharmacy and a 2006 Distinguished Purdue Alumnus.